Cargando…

Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway

Of all pathological types of renal cell cancer (RCC), clear cell renal cell carcinoma (ccRCC) has the highest incidence. Cyclovirobuxine (CVB), a triterpenoid alkaloid isolated from Buxus microphylla, exhibits antitumour activity against gastric cancer and breast cancer; however, the mechanism by wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yadong, Lv, Huiyan, Li, Xingyi, Liu, Jiannan, Chen, Song, Chen, Yaodong, Jin, Yinshan, An, Ruihua, Yu, Shiliang, Wang, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416721/ https://www.ncbi.nlm.nih.gov/pubmed/34512163 http://dx.doi.org/10.7150/ijbs.62114

Ejemplares similares

Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1-AKT/ERK-Snail signaling pathway
por: Jiang, Fengqi, et al.
Publicado: (2020)

Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway
por: Liu, Yadong, et al.
Publicado: (2020)

H3 relaxin protects against calcium oxalate crystal‐induced renal inflammatory pyroptosis
por: Liu, Jiannan, et al.
Publicado: (2020)

Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
por: Jin, Yinshan, et al.
Publicado: (2020)

IGFBP2 potentiates nuclear EGFR-STAT3 signaling
por: Chua, Corrine Yingxuan, et al.
Publicado: (2015)

Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis
por: Wang, Jianxin, et al.
Publicado: (2023)

Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
por: Gao, Ge, et al.
Publicado: (2022)

Cyclovirobuxine D Induced-Mitophagy through the p65/BNIP3/LC3 Axis Potentiates Its Apoptosis-Inducing Effects in Lung Cancer Cells
por: Zeng, Cheng, et al.
Publicado: (2021)

Cyclovirobuxine D Inhibits Cell Proliferation and Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer Cells
por: Wu, Jie, et al.
Publicado: (2015)

Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D
por: Ke, Zhongcheng, et al.
Publicado: (2016)

SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
por: Masuo, Kenji, et al.
Publicado: (2021)

Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
por: Guo, Qian, et al.
Publicado: (2015)

Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020)

Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin
por: Zhang, Lin, et al.
Publicado: (2021)

IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
por: Sun, Longhao, et al.
Publicado: (2022)

IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
por: Cai, Qing, et al.
Publicado: (2020)

IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma
por: Kunhiraman, Haritha, et al.
Publicado: (2023)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer
por: Wang, Zhigang, et al.
Publicado: (2013)

Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low-grade glioma
por: Zhou, Lingqi, et al.
Publicado: (2020)

SALIS transcriptionally represses IGFBP3/Caspase-7-mediated apoptosis by associating with STAT5A to promote hepatocellular carcinoma
por: Liu, Xingyuan, et al.
Publicado: (2022)

Clinical significance of serum IGFBP‐3 in colorectal cancer
por: Hou, Yu‐Lei, et al.
Publicado: (2019)

Rhein Inhibits the Progression of Chemoresistant Lung Cancer Cell Lines via the Stat3/Snail/MMP2/MMP9 Pathway
por: Liu, Jinxin, et al.
Publicado: (2022)

IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
por: Honda, Makoto, et al.
Publicado: (2009)

Biochemical determinants of the IGFBP‐3–hyaluronan interaction
por: Dorandish, Sadaf, et al.
Publicado: (2020)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Association study of IGFBP1 and IGFBP3 polymorphisms with hypertension and cardio-cerebral vascular diseases in a Chinese Han population
por: Fang, Zhengmei, et al.
Publicado: (2017)

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G(2)/M phase transition regulatory network and the NFκB/JNK signaling pathway
por: Xue, Ting, et al.
Publicado: (2023)

Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells
por: Igarashi, Ko, et al.
Publicado: (2020)

OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer
por: Cai, Qing, et al.
Publicado: (2020)

Snail heterogeneity in clear cell renal cell carcinoma
por: Zaldumbide, Laura, et al.
Publicado: (2016)

Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows
por: Mense, Kirsten, et al.
Publicado: (2018)

DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest
por: Gao, Ke, et al.
Publicado: (2023)

Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly via inhibition of voltage-gated Ca(v)3.2 channels
por: Su, Deyuan, et al.
Publicado: (2022)

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway
por: Wang, Danning, et al.
Publicado: (2020)

Correlation between Salivary Levels of IGF-1, IGFBP-3, IGF-1/IGFBP3 Ratio with Skeletal Maturity Using Hand-Wrist Radiographs
por: Almalki, Abdullah, et al.
Publicado: (2022)

Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study
por: Tamimi, Rulla M, et al.
Publicado: (2007)

IGFBP‐3 inhibits Wnt signaling in metastatic melanoma cells
por: Naspi, Antimo, et al.
Publicado: (2016)

Hsa‐microRNA‐370‐3p targeting Snail and Twist1 suppresses IL‐8/STAT3‐driven hepatocellular carcinoma metastasis
por: Peng, Siqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jk285scavmq830uvko26r4mh6h